BIOMAT Database Logo BIOMAT Database Logo

Third-generation cephalosporin-resistant pneumococcal meningitis in children. 2021

Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Center for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan.

UI MeSH Term Description Entries
D008586 Meningitis, Pneumococcal An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111) Meningitis, Streptococcus pneumoniae,Experimental Pneumococcal Meningitis,Meningitis, Pneumococcal, Experimental,Meningitis, Pneumococcal, Penicillin-Resistant,Meningitis, Pneumococcal, Recurrent,Experimental Pneumococcal Meningitides,Meningitides, Streptococcus pneumoniae,Meningitis, Experimental Pneumococcal,Pneumococcal Meningitides,Pneumococcal Meningitides, Experimental,Pneumococcal Meningitis,Pneumococcal Meningitis, Experimental,Streptococcus pneumoniae Meningitides,Streptococcus pneumoniae Meningitis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin

Related Publications

Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
A Rare Case of Third Generation Cephalosporin-Resistant Klebsiella Meningitis.
May 2022, Cureus,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.
February 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
November 2001, Antimicrobial agents and chemotherapy,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Third-generation cephalosporin-resistant Vibrio cholerae, India.
August 2012, Emerging infectious diseases,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Third generation cephalosporin-resistant gram-negative bacilli in the feces of hospitalized children.
February 1995, The Pediatric infectious disease journal,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Management and Outcomes in Children with Third-Generation Cephalosporin-Resistant Urinary Tract Infections.
May 2021, Journal of the Pediatric Infectious Diseases Society,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
October 1998, Antimicrobial agents and chemotherapy,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Penicillin- and third-generation cephalosporin-resistant strains of Streptococcus pneumoniae meningitis: Case report and literature review.
May 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
March 2000, The Journal of antimicrobial chemotherapy,
Hiroyuki Aiba, and Kensuke Shoji, and Daisuke Shinjo, and Akira Ishiguro, and Isao Miyairi
Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
November 1997, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!